# A Study to Examine the Efficacy of a Therapeutic THX-110 for Obstructive Sleep Apnea

> **NCT03646552** · PHASE2 · UNKNOWN · sponsor: **Neurothera Labs Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** THX-110

## Key facts

- **NCT ID:** NCT03646552
- **Lead sponsor:** Neurothera Labs Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-04
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03646552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03646552, "A Study to Examine the Efficacy of a Therapeutic THX-110 for Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03646552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*